Literature DB >> 17924416

Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas.

Huicong Zhao1, Daniza Mandich, Richard W Cartun, Saverio Ligato.   

Abstract

We evaluated the immunocytochemical (ICC) expression of K homology domain containing protein overexpressed in cancer (KOC) in pancreatic endoscopic ultrasound-guided fine needle aspirates (EUS-FNAs) to assess its potential use as an adjunct in differentiating nonneoplastic (GI epithelium) and benign neoplastic epithelia (benign epithelial pancreatic neoplasms) from pancreatic adenocarcinoma cells. Forty-eight cases of EUS-FNAs with histological and/or clinical follow-up data were selected for this study. Alcohol-fixed and PAP-stained slides were stained with monoclonal antibody to KOC/L523S (clone 69.1). Results were recorded as negative or positive. KOC expression was present in 35/40 (88%) of adenocarcinomas (Ac) and was negative in all eight benign cases. The sensitivity and specificity were as follows: cytology 85 and 100%, KOC 88 and 100%; combination of cytology and KOC 95 and 100%. We conclude that KOC ICC expression on alcohol-fixed smears along with cytology improves the sensitivity of EUS-FNAs in the diagnosis of pancreatic Ac, and KOC reactivity is especially useful in differentiating Ac from nonneoplastic gastrointestinal epithelium and benign neoplastic epithelia. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17924416     DOI: 10.1002/dc.20739

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  13 in total

1.  The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.

Authors:  Jody E Hooper; Terry K Morgan; Markus Grompe; Brett C Sheppard; Megan L Troxell; Christopher L Corless; Philip R Streeter
Journal:  Hum Pathol       Date:  2012-03-09       Impact factor: 3.466

2.  Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.

Authors:  Terry K Morgan; Karin Hardiman; Christopher L Corless; Sandra L White; Robert Bonnah; Henry Van de Vrugt; Brett C Sheppard; Markus Grompe; Ediz F Cosar; Philip R Streeter
Journal:  Cancer Cytopathol       Date:  2012-07-18       Impact factor: 5.284

3.  IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis.

Authors:  Marc-Oliver Riener; Josef Hoegel; Heinrich Iro; Arndt Hartmann; Abbas Agaimy
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

4.  MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma.

Authors:  Nicole C Panarelli; Yao-Tseng Chen; Xi K Zhou; Naoki Kitabayashi; Rhonda K Yantiss
Journal:  Pancreas       Date:  2012-07       Impact factor: 3.327

5.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival.

Authors:  David F Schaeffer; Daniel R Owen; Howard J Lim; Andrew K Buczkowski; Stephen W Chung; Charles H Scudamore; David G Huntsman; Sylvia S W Ng; David A Owen
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

Review 6.  Cell-block procedure in endoscopic ultrasound-guided-fine-needle-aspiration of gastrointestinal solid neoplastic lesions.

Authors:  Antonio Ieni; Valeria Barresi; Paolo Todaro; Rosario Alberto Caruso; Giovanni Tuccari
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

7.  Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures.

Authors:  Hans Dieter Nischalke; Volker Schmitz; Carolin Luda; Katharina Aldenhoff; Cordula Berger; Georg Feldmann; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

8.  The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion.

Authors:  Clarissa C Pasiliao; Che-Wei A Chang; Brent W Sutherland; Shannon M Valdez; David Schaeffer; Donald T Yapp; Sylvia S W Ng
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

Review 9.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

Authors:  Jessica L Bell; Kristin Wächter; Britta Mühleck; Nikolaos Pazaitis; Marcel Köhn; Marcell Lederer; Stefan Hüttelmaier
Journal:  Cell Mol Life Sci       Date:  2012-10-16       Impact factor: 9.261

10.  Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel.

Authors:  Asif Ali; Victoria Brown; Simon Denley; Nigel B Jamieson; Jennifer P Morton; Colin Nixon; Janet S Graham; Owen J Sansom; C Ross Carter; Colin J McKay; Fraser R Duthie; Karin A Oien
Journal:  BMC Clin Pathol       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.